Anterogen Co. Ltd. | Mutual Funds
Mutual Funds that own Anterogen Co. Ltd.
34,641
0.44%
0
0.82%
09/06/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
5,158
0.07%
0
0.01%
09/05/2018
iShares III Plc - MSCI Emerging Markets Small Cap
2,206
0.03%
0
0.05%
09/05/2018
iShares MSCI Emerging Markets Small Cap ETF
1,680
0.02%
0
0.06%
09/05/2018
SPDR S&P World (ex-US) ETF
1,059
0.01%
0
0%
09/06/2018
iShares II Plc - MSCI AC Far East (ex-Japan) Small Cap
418
0.01%
0
0.06%
09/05/2018
SSgA SPDR ETFs Europe I Plc - MSCI Em. Mkts. Small Cap UCITS
379
0.01%
0
0.05%
09/05/2018
137
0%
137
0.14%
07/06/2018
| Address |
Unit 405, Namsung Plaza
Seoul SL 08589
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.anterogen.com |
| Updated |
09/14/2018 |
| Anterogen Co., Ltd. develops stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell and stem cell conditioned media. In addition, It also offers stem cell banking and analysis services. |
